Clinical trial
A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol.
NCT00443534 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00443534 |
|---|---|
| Title | A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol. |
| Official title | A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol. |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Neoplasms |
| Intervention type | Drug |
| Interventions | SU011248 |
| Enrollment | 123 |
| Start date | May 1, 2006 |
| Primary completion | Dec 1, 2011 |
| Completion | Dec 1, 2011 |
| First posted | Mar 6, 2007 |
| Last update posted | May 24, 2013 |
| Countries | Canada, France, Germany, Italy, Spain, United Kingdom, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: